AzTrials
AzTrials

Critical IllnessLANTERNNCT06006000

Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness

An observational study of Critical Illness and Illness, Critical, run by Yale University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a prospective longitudinal study that will evaluate the unmet needs of older adults (65 and older) who return home (either directly or after short-term rehab) after an ICU hospitalization, evaluate the association of these unmet needs with clinically relevant outcomes, and assess barriers and facilitators to… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Critical Illness, Illness, Critical
How many people
350 participants
Where
1 siteUnited States
Study dates
25 Jan 2024to Oct 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Community-dwelling older adults who return home (either directly or after a stay in short-term rehab (STR)) after an ICU hospitalization.

Who may be able to join

  • PARTICIPANTS
  • Age ≥ 65 years
  • Survived an ICU admission of ≥2 days
  • CAREGIVERS
  • Age ≥ 18 years
  • Identified as caregiver of LANTERN participant who is an informal (unpaid) caregiver.

Who cannot join

  • PARTICIPANTS
  • Advance directive of comfort measures only (CMO) or a transition to hospice
  • Planned discharge to a location other than home or Short-Term Rehab
  • Tracheostomy with ventilator dependence
  • Severe acute or prior neurologic injury (such as anoxic brain injury or acute, massive stroke)
  • Advanced dementia
Show all 14Show fewer
  • ICU admission for monitoring only (e.g., antibiotic desensitization)
  • Primary language other than English.
  • Homelessness
  • Active drug or alcohol use disorder.
  • CAREGIVERS
  • Primary language other than English
  • Is a paid caregiver
  • Unwilling to complete a qualitative interview

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nicole Bouranis, PhD contact

+1 (203) 737-1731

nicole.bouranis@yale.edu

United States1 site, 1 recruiting
  • Yale New Haven Hospital

    New Haven, Connecticut, 06520

    Recruiting

Other trials in United States

About this study

This is a prospective longitudinal study that will evaluate the unmet needs of older adults (65 and older) who return home (either directly or after short-term rehab) after an ICU hospitalization, evaluate the association of these unmet needs with clinically relevant outcomes, and assess barriers and facilitators to addressing these unmet needs. The proposed research will inform the development and evaluation of a subsequent intervention to improve functional outcomes among older ICU survivors, in alignment with the NIH's mission to reduce disability.

Read the detailed description

To identify unmet needs in multiple domains after return home from an ICU hospitalization, evaluate whether these unmet needs are associated with disability burden in the subsequent 6 months, and ascertain whether these associations are moderated by initial discharge destination (home or STR).

Keywords
Geriatrics, Older Adults
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06006000
Study groupRoleWhat they receive
Older adults returning home post-ICUCommunity-dwelling older adults who return home (either directly or after a stay in short-term rehab (STR)) after an ICU hospitalization.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disability Count

    Number of instances of disability during activities of daily living (ADLs), instrumental activities of daily living (IADLs), and mobility activity. Disability is defined as an inability to complete the task or the need for personal assistance to complete the task. The higher the count, the more disability.

    Measured: monthly up to 6 months

  2. Number of hospital readmissions

    Number of hospital readmissions monthly up to 6 months.

    Measured: monthly up to 6 months

  3. Number of deaths

    Number of deaths each month up to 6 months.

    Measured: monthly up to 6 months

  4. Barriers and Facilitators to addressing unmet needs

    Barriers and facilitators to addressing unmet needs will be assessed using qualitative interviews. A subgroup of participants will receive qualitative interviews conducted with members of the study team. Content analysis will then be used to identify barriers and facilitators to addressing unmet needs that will be informative when planning a future intervention.

    Measured: month 6

Secondary outcomes (1)
  1. Functional non-recovery

    Not returning to the pre-ICU functional baseline within the follow-up period

    Measured: monthly up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Aug 2023
  2. Study start25 Jan 2024
  3. Primary completionOct 2028 (estimated)
  4. Study completionOct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
350 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06006000
Sponsor's protocol ID
2000034943
Other IDs
1R01AG079916-01A1
Acronym
LANTERN
Status last verified
Jun 2026
First submitted
15 Aug 2023
Last updated
17 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified data from this study will be available to investigators who sign a Data Use Agreement (DUA) executed between Yale University and the investigator's institution. The DUA requires the investigators to attest to (1) their commitment to using the data only for approved research purposes and not to identify any individual human participant; (2) their commitment to securing the data using appropriate computer technology; and (3) their commitment to destroying or returning the data after analyses are completed. Data will not be available until all analyses are complete.

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness and Illness, Critical, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nicole Bouranis, PhD (+1 (203) 737-1731, nicole.bouranis@yale.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disability Count (time frame: monthly up to 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in